menu search

Composecure: leading metal card provider set to benefit from a growing market

The metal payment card market is expected to triple by 2025, growing from a little under 30 million car...

January 4, 2023, 1:01 am

Tesla locks battery material supply; this lithium stock soars

Tesla amended its supply agreement with Piedmont Lithium, securing the EV giant's lithium deliveries through 2...

January 3, 2023, 9:34 am

Piedmont lithum stock jumps 9% premarket on news of new lithium delivery deal with tesla

Piedmont Lithium Inc. PLL, +0.94% said Tuesday it has amended its agreement with Tesla Inc. to supply the electric vehicle maker with spodumene concen...

January 3, 2023, 7:07 am

Disc medicine announces completion of merger with gemini therapeutics

The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON” Approximately $175 mi...

December 29, 2022, 10:15 pm

Albemarle: sodium-ion battery is no threat to lithium yet

Despite the early hype, Sodium-Ion batteries may only offer an energy density of up to 200Wh/kg, against those currently offered by Lithium-Ion at 350...

December 28, 2022, 4:00 pm

Apple likely won't make big move in foldable products anytime soon, says analyst

TF International Securities analyst Ming-Chi Kuo said Apple was unlikely to replace its iPad mini range with a foldable version in 2...

December 27, 2022, 10:43 am

Japan's kyocera to invest $9.8 bln for chips over fy2023-2025 -nikkei

Japan's Kyocera Corp plans to invest 1.3 trillion yen ($9.77 billion) for manufacturing facilities and development of semiconductor-related products o...

December 27, 2022, 4:36 am

Experian: navigating volatility in 2023 through non-traditional defensives

Revenue consensus estimates from 2023 to 2025 is expected to grow at a 5.95% CAGR, compared to a 0.3% a...

December 26, 2022, 7:07 pm

Tesla investors growing concerned about musk's distraction with twitter, says wsj's tim higgins

Tim Higgins, Wall Street Journal tech reporter, joins 'Closing Bell' to discuss Tesla's down year and reacts to the news that Musk says he likely won'...

December 23, 2022, 5:10 pm

Musk to stop selling tesla shares for '18 24 months'

Elon Musk said that he'll stop selling Tesla Inc. shares, "until 2025, or something," after disposing a...

December 23, 2022, 6:01 am

Ardc: this fixed income fund trades at a wide discount and yields 10.5%

Since I last wrote about ARDC in August, the discount has widened to more than -13% while the NAV has stabilized. Based on the current monthly distrib...

December 23, 2022, 4:19 am

Tesla ceo musk says he won't be selling any more tsla shares until 2025. d'ya believe him?

The price of TSLA has jumped on the statement from founder and CEO Elon Musk.

Musk has been a big seller of the shares this year, helping to ...

December 22, 2022, 10:55 pm

Musk: probably won't sell any more tesla stock till 2025

CNBC's Pippa Stevens reports that Elon Musk has said he probably won't sell any more Tesla stock until 2025...

December 22, 2022, 6:17 pm

Beacon (becn) on expansion spree, unviels greenfield branches

Beacon's (BECN) latest announcement substantiates its commitment to make Ambition 2025 investments to d...

December 22, 2022, 6:04 pm

3m (mmm) to cease manufacture of harmful pfas by 2025-end

3M's (MMM) decision to stop producing PFAS follows regulatory pressure to limit the use of this harmful chemical. The company expects to record a pre-...

December 22, 2022, 11:18 am

General motors: unlikely to meet 2025 revenue target, but stock still attractive

General Motors forecasts its overall sales and EV revenue to reach $225 billion and $50 billion, respectively, by 2...

December 22, 2022, 10:28 am

Nasdaq bear market: 3 industry-leading stocks that can double your money by 2025

Investing in best-of-breed businesses is a smart way to take advantage of a greater than 30% plunge in the Nasdaq Composite....

December 22, 2022, 5:06 am

Oric pharmaceuticals announces clinical development collaboration with pfizer for oric-533 in multiple myeloma and concurrent $25 million equity investment by pfizer

ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study of ORIC-533 in combination with elranatamab in multiple mye...

December 21, 2022, 10:48 pm


Search within

Pages Search Results: